Nanjing Vazyme Biotech Statistics

Total Valuation

SHA:688105 has a market cap or net worth of CNY 9.03 billion. The enterprise value is 7.22 billion.

Market Cap	9.03B
Enterprise Value	7.22B

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	Jun 5, 2025

Share Statistics

SHA:688105 has 397.73 million shares outstanding. The number of shares has decreased by -23.47% in one year.

Current Share Class	397.73M
Shares Outstanding	397.73M
Shares Change (YoY)	-23.47%
Shares Change (QoQ)	+6.67%
Owned by Insiders (%)	12.90%
Owned by Institutions (%)	12.21%
Float	114.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	94.63
PS Ratio	6.64
PB Ratio	2.32
P/TBV Ratio	2.45
P/FCF Ratio	n/a
P/OCF Ratio	537.72
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-337.17
EV / Sales	5.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-172.26

Financial Position

The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.28.

Current Ratio	3.33
Quick Ratio	2.94
Debt / Equity	0.28
Debt / EBITDA	101.26
Debt / FCF	-26.01
Interest Coverage	-5.01

Financial Efficiency

Return on equity (ROE) is -0.57% and return on invested capital (ROIC) is -1.57%.

Return on Equity (ROE)	-0.57%
Return on Assets (ROA)	-1.48%
Return on Invested Capital (ROIC)	-1.57%
Return on Capital Employed (ROCE)	-3.09%
Revenue Per Employee	474,820
Profits Per Employee	-7,464
Employee Count	2,867
Asset Turnover	0.25
Inventory Turnover	1.19

Taxes

Income Tax	-37.52M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.97% in the last 52 weeks. The beta is 0.96, so SHA:688105's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+1.97%
50-Day Moving Average	22.85
200-Day Moving Average	22.44
Relative Strength Index (RSI)	52.12
Average Volume (20 Days)	1,990,123

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688105 had revenue of CNY 1.36 billion and -21.40 million in losses. Loss per share was -0.07.

Revenue	1.36B
Gross Profit	923.91M
Operating Income	-126.70M
Pretax Income	-60.16M
Net Income	-21.40M
EBITDA	-31.81M
EBIT	-126.70M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 2.91 billion in cash and 1.09 billion in debt, giving a net cash position of 1.82 billion or 4.57 per share.

Cash & Cash Equivalents	2.91B
Total Debt	1.09B
Net Cash	1.82B
Net Cash Per Share	4.57
Equity (Book Value)	3.90B
Book Value Per Share	9.81
Working Capital	2.70B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.80 million and capital expenditures -58.69 million, giving a free cash flow of -41.89 million.

Operating Cash Flow	16.80M
Capital Expenditures	-58.69M
Free Cash Flow	-41.89M
FCF Per Share	-0.11

Full Cash Flow Statement

Margins

Gross margin is 67.87%, with operating and profit margins of -9.31% and -1.57%.

Gross Margin	67.87%
Operating Margin	-9.31%
Pretax Margin	-4.42%
Profit Margin	-1.57%
EBITDA Margin	-2.34%
EBIT Margin	-9.31%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.31%.

Dividend Per Share	0.30
Dividend Yield	1.31%
Dividend Growth (YoY)	80.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	23.47%
Shareholder Yield	24.79%
Earnings Yield	-0.24%
FCF Yield	-0.46%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688105 has an Altman Z-Score of 5.01 and a Piotroski F-Score of 5.

Altman Z-Score	5.01
Piotroski F-Score	5